Pharmatizing AI

Digital

In this off-the-stage interview from Frontiers Health 2025 discover how 'pharmatized' AI delivers smarter, faster, and more reliable innovation.

News

At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, now named Tudriqev and its first product.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.